Osteoprotegerin in Cardiometabolic Disorders

Osteoprotegerin (OPG), a glycoprotein traditionally implicated in bone remodelling, has been recently related to cardiovascular disease (CVD). Human studies show a positive relationship between circulating OPG, vascular damage, and CVD, and as such OPG has emerged as a potential biomarker for CVD. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez de Ciriza, C., Lawrie, A., Varo, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442310/
https://www.ncbi.nlm.nih.gov/pubmed/26078757
http://dx.doi.org/10.1155/2015/564934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442310/
https://www.ncbi.nlm.nih.gov/pubmed/26078757
http://dx.doi.org/10.1155/2015/564934

Ejemplares similares